MUMBAI -India's Sun Pharmaceutical Industries Ltd. (524715.BY) Monday said its unit has received approval from the U.S. Food and Drug Administration to make and sell Bethanechol Chloride tablets in 5 milligram, 10 mg, 25 mg and 50 mg doses.
Sun Pharmaceutical Industries Inc. will make and sell the generic equivalent of Urecholine tablets marketed by Odyssey Pharmaceuticals Inc.
Bethanechol Chloride is used to treat acute postoperative and postpartum nonobstructive (functional) urinary retention.
No comments:
Post a Comment